Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
NCT00174863
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
232
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasm
Interventions
DRUG:
SR31747A
Sponsor
Sanofi